Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
04/09/2002 | US6368845 Polypeptides having L-asparaginase activity |
04/09/2002 | US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes |
04/09/2002 | US6368833 Esterases, DNA encoding therefor and vectors and host incorporating same |
04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
04/09/2002 | US6368819 Microbial process for the preparation of acetic acid as well as solvent for its extraction from the fermentation broth |
04/09/2002 | US6368804 Method for stabilizing nitrilase activity and preserving microbial cells |
04/09/2002 | US6368793 Metabolic selection methods |
04/09/2002 | US6368787 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
04/09/2002 | US6368784 A dual-purpose buffer consisting of an intracellular ionic strength andph mimicking buffer and also containing antioxidants, phosphorylated nucleotides and water |
04/09/2002 | US6368623 Mixing with metal compound, atomizing |
04/09/2002 | US6368591 Comprising the bacteria bifidobacterium bifidum 6-1 (cctcc number m 98003), lactobacillus acidophilus yit 2004 (cctcc number m 98004) and streptococcus faecalis yit 0027 (cctcc number m 98005); treating acute hepatitis, liver injuries |
04/09/2002 | US6368589 Hybrid gene |
04/09/2002 | US6368580 Gastrointestinal disorders; oral administering bacillus |
04/09/2002 | US6368019 Method for soil remediation |
04/09/2002 | CA2253006C .beta.-carotene hydroxylase gene |
04/09/2002 | CA2229754C Method for culturing microorganism, method for biosynthesizing organic compound, method for maintaining microbial ability to decompose polluting substance, method for decomposing pollutant, and method for remedying environment |
04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
04/09/2002 | CA2009306C Expression systems for amidating enzyme |
04/04/2002 | WO2002027009A1 Nucleotide sequences which code for the mike17 gene |
04/04/2002 | WO2002027008A1 Promoter sequences |
04/04/2002 | WO2002027000A1 Nucleotide sequences which code for the dep67 protein |
04/04/2002 | WO2002026998A2 Hydrolases |
04/04/2002 | WO2002026989A1 Nucleotide sequences which code for the msik gene |
04/04/2002 | WO2002026988A2 Human drug metabolizing enzymes |
04/04/2002 | WO2002026982A2 Secreted human proteins |
04/04/2002 | WO2002026980A2 Human ion-exchanger proteins and polynucleotides encoding t he same |
04/04/2002 | WO2002026979A1 NOVEL ENZYME HAVING β-GLUCOSIDASE ACTIVITY AND USE THEREOF |
04/04/2002 | WO2002026963A1 Shingolipid ceramide deacylase gene |
04/04/2002 | WO2002026961A2 Production process of surfactin |
04/04/2002 | WO2002026954A2 Truncated phosphodiesterase-7 polypeptides |
04/04/2002 | WO2002026951A2 Oxidoreductases |
04/04/2002 | WO2002026950A2 Transferases |
04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
04/04/2002 | WO2002026945A2 Regulation of human aminotransferase-like enzyme |
04/04/2002 | WO2002026938A1 Liquid yeast activator, solid yeast activator, process for producing the same and process for producing fermented product |
04/04/2002 | WO2002026937A1 Chemical substance for protection of brain nerve cell and method for producing thereof |
04/04/2002 | WO2002026933A2 Isoprenoid production |
04/04/2002 | WO2002026929A2 Kini-3 motor protein and methods for its use |
04/04/2002 | WO2002026832A1 Antibodies for human cytochrome p450 2d6 |
04/04/2002 | WO2002026825A2 G-protein coupled receptors |
04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
04/04/2002 | WO2002026819A2 Recombinant bcg vaccines for the prevention and treatment of cancer |
04/04/2002 | WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
04/04/2002 | WO2002026804A2 84241, a human ring finger family member and uses thereof |
04/04/2002 | WO2002026787A1 Nucleotide sequences which code for the dead gene |
04/04/2002 | WO2002026786A1 Nucleotide sequences which code for the trub gene |
04/04/2002 | WO2002026755A2 Nucleotide sequences which code for the ppgk gene |
04/04/2002 | WO2002026250A2 Vaccines for proliferative ileitis |
04/04/2002 | WO2002026041A2 A novel strain of streptomyces for controlling plant diseases |
04/04/2002 | WO2002010209A8 Nucleotide sequences which code for the meth gene |
04/04/2002 | WO2002008435A8 Codon-optimized papilloma virus sequences |
04/04/2002 | WO2001094544A3 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification |
04/04/2002 | WO2001090306A3 Compositions and methods for modulating tumor specific expression |
04/04/2002 | WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants |
04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
04/04/2002 | WO2001085921A3 Human serine-threonine kinase-4 |
04/04/2002 | WO2001083767A3 Nucleotide sequences coding for the cls gene |
04/04/2002 | WO2001083765A3 Nucleotides sequences coding for the cdsa gene |
04/04/2002 | WO2001083699A3 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family |
04/04/2002 | WO2001079462A3 Nucleic acids encoding polypeptides having haloperoxidase activity |
04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
04/04/2002 | WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
04/04/2002 | WO2001072781A3 Human genes and expression products |
04/04/2002 | WO2001070988A3 Receptors for hypersensitive response elicitors and uses thereof |
04/04/2002 | WO2001068821A3 Novel subtilase enzymes having an improved wash performance on egg stains |
04/04/2002 | WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto |
04/04/2002 | WO2001066741A3 Kcnb: a novel potassium channel protein |
04/04/2002 | WO2001064896A3 Human enzyme molecules |
04/04/2002 | WO2001064227A3 Androgenic activity of eucommia ulmoides extracts |
04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
04/04/2002 | WO2001053352A3 Sperm specific proteins |
04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
04/04/2002 | WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
04/04/2002 | US20020040488 Synthases |
04/04/2002 | US20020040487 To provide a plant not showing livestock toxicity due to symbiotic fungi with which it is infected, and having strong resistance to pests, symbiotic fungus |
04/04/2002 | US20020040485 Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate) |
04/04/2002 | US20020040129 Nucleotide sequences encoding the glk-gene |
04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
04/04/2002 | US20020040009 Novel ratA |
04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
04/04/2002 | US20020039782 Method of rapid bio-cycling of an aquarium |
04/04/2002 | US20020039781 Fermentation post-sterile additive delivery method and apparatus |
04/04/2002 | US20020039779 Transcriptional regulator |
04/04/2002 | US20020039777 Cdna encoding plant-derived epoxide hydrolase, gene encoding same and transformant |
04/04/2002 | US20020039770 Forming hydroxy group containing acid from hydroxy groupcontaining nitrile; polylactones |
04/04/2002 | US20020039768 Percyquinnin, a process for its production and its use as a pharmaceutical |
04/04/2002 | US20020039765 Viral polypeptide for use as tool in genetic engineering and gene therapy |
04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
04/04/2002 | US20020039761 Ketogulonigenium shuttle vectors |
04/04/2002 | US20020039759 Polypeptide for use in the prevention of bacterial infection |